Please enable Javascript
The HemOnc Pulse
Meeting News
The HemOnc Pulse Live
Video Insights
In Print
Subscribe
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Lymphoma
Aggressive B-Cell Lymphoma
Hodgkin Lymphoma
Indolent B-Cell Lymphoma
Mantle Cell Lymphoma
T-Cell Lymphoma
MPN
Myelofibrosis
Polycythemia Vera
MDS
Myeloma
Transplantation & Cellular Therapy
Alan Skarbnik, MD
Articles by Alan Skarbnik, MD
'The HemOnc Pulse' Live Part Two: The Question of MRD in CLL Therapy
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
August 22, 2024
Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD continue their discussion on MRD in CLL during HOP Live 2024.
Listen Now
'The HemOnc Pulse' Live Part One: The Question of MRD in CLL Therapy
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
September 3, 2024
This episode explores questions in CLL with Mazyar Shadman, MD; Meghan Thompson, MD; Alan Skarbnik, MD during HOP Live 2024.
Listen Now
'The HemOnc Pulse' Live: Unanswered Questions in Aggressive Non-Hodgkin Lymphoma
Greg Nowakowski, MD
The HemOnc Pulse Live
|
May 28, 2024
An expert panel convened at the "HemOnc Pulse" Live meeting in Chicago explores unanswered questions in DLBCL management.
Listen Now
'The HemOnc Pulse' Live 2024 in Chicago: CAR-T Unanswered Questions
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse Live
|
July 26, 2024
Live from Chicago, the panel discussed unanswered questions in CAR-T.
Listen Now
What are the Controversies Surrounding MRD in Blood Cancers?
Chadi Nabhan, MD, MBA, FACP
The HemOnc Pulse: MRD
|
September 12, 2024
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Listen Now
ASH 2023: What Is the Latest ‘Practice-Changing’ Research in DLBCL?
Chadi Nabhan, MD, MBA, FACP
Aggressive B-Cell Lymphoma
|
December 14, 2023
In this episode of The HemOnc Pulse, Alan Skarbnik, MD, of Novant Health, discusses practice-changing research in DLBCL.
Listen Now